Medicare can pay for obesity drugs like Wegovy in certain heart patients
Medicare can pay for the popular weight-loss drug Wegovy — as long as the patients using it also have heart disease and need to reduce the risk of future heart attacks, strokes and other serious problems, federal officials said Thursday.
The Centers for Medicare & Medicaid Services issued new guidance that says Medicare Part D drug benefit plans — which are offered through private insurers — could cover anti-obesity drugs that are approved for an additional use.
The move could pave the way for thousands of new prescriptions, resulting in billions of dollars in increased spending, analysts have said.
In practice, the guidance opens the door to wider coverage of Wegovy, the brand name of Novo Nordisk’s obesity medication semaglutide. The U.S. Food and Drug Administration this month approved a label change that allows Wegovy to be used to reduce the risk of cardiovascular events in people who are overweight or have obesity and also have existing heart disease.
Related articles
This is the surprising risk of Ozempic NO ONE talks about
Eight months ago, the mood in my therapy room shifted considerably. Clients who had been suffering f2024-05-07- He was as bitter as she was sweet. But nobody ever said a word against the Queen Mother's kid brothe2024-05-07
- What is the recipe for the perfect modern royal look?For the Princess of Wales, it’s coat dresses an2024-05-07
- He is known as the dashing society photographer who became Princess Margaret’s husband. Born on this2024-05-07
Turkey says it has carried out new airstrikes against Kurdish militants in northern Iraq
ANKARA, Turkey (AP) — Turkey has carried out a new round of airstrikes targeting Kurdish militants i2024-05-07Sandringham House is filled with the spirit of the King's gentle
King Charles will have plenty to keep him occupied at Sandringham House in the coming days and weeks2024-05-07
atest comment